

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.79707395 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.19131946 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.19131946 |
| 4 | nuclear pore organization (GO:0006999) | 6.09069145 |
| 5 | DNA unwinding involved in DNA replication (GO:0006268) | 5.96198691 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.90616109 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.90616109 |
| 8 | lysine catabolic process (GO:0006554) | 5.55134714 |
| 9 | lysine metabolic process (GO:0006553) | 5.55134714 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.29279017 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.18673103 |
| 12 | pore complex assembly (GO:0046931) | 5.13998389 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 5.10651827 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.07214640 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.95060621 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.92927296 |
| 17 | mitotic chromosome condensation (GO:0007076) | 4.89153101 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.86782986 |
| 19 | DNA strand elongation (GO:0022616) | 4.70980720 |
| 20 | establishment of integrated proviral latency (GO:0075713) | 4.66938905 |
| 21 | aspartate family amino acid catabolic process (GO:0009068) | 4.62964682 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.59591331 |
| 23 | mitotic sister chromatid cohesion (GO:0007064) | 4.57904294 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 4.51501252 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.50423736 |
| 26 | ketone body metabolic process (GO:1902224) | 4.45318349 |
| 27 | urea metabolic process (GO:0019627) | 4.44710491 |
| 28 | urea cycle (GO:0000050) | 4.44710491 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.42797043 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 4.42797043 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 4.42797043 |
| 32 | regulation of translational fidelity (GO:0006450) | 4.40956876 |
| 33 | tryptophan metabolic process (GO:0006568) | 4.34973966 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 4.33699079 |
| 35 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.31817106 |
| 36 | cysteine metabolic process (GO:0006534) | 4.31097259 |
| 37 | protein complex localization (GO:0031503) | 4.22638529 |
| 38 | carnitine shuttle (GO:0006853) | 4.18069437 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 4.16982803 |
| 40 | short-chain fatty acid metabolic process (GO:0046459) | 4.11374125 |
| 41 | acetyl-CoA metabolic process (GO:0006084) | 4.08121515 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.07217949 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.05915618 |
| 44 | protein localization to chromosome, centromeric region (GO:0071459) | 4.05278316 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.05208055 |
| 46 | ribosome assembly (GO:0042255) | 4.05072221 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 4.01654647 |
| 48 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.00435362 |
| 49 | fatty acid beta-oxidation (GO:0006635) | 3.98567761 |
| 50 | DNA replication initiation (GO:0006270) | 3.97885141 |
| 51 | cellular protein complex localization (GO:0034629) | 3.96453314 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 3.96444229 |
| 53 | glutamate metabolic process (GO:0006536) | 3.93785103 |
| 54 | mitotic nuclear envelope disassembly (GO:0007077) | 3.92600603 |
| 55 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.84699594 |
| 56 | formation of translation preinitiation complex (GO:0001731) | 3.84586350 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 3.80753333 |
| 58 | bile acid metabolic process (GO:0008206) | 3.78932658 |
| 59 | complement activation, alternative pathway (GO:0006957) | 3.78501442 |
| 60 | pre-miRNA processing (GO:0031054) | 3.77688301 |
| 61 | reverse cholesterol transport (GO:0043691) | 3.76152232 |
| 62 | fatty acid oxidation (GO:0019395) | 3.75356026 |
| 63 | DNA duplex unwinding (GO:0032508) | 3.75306520 |
| 64 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.74874278 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.74806871 |
| 66 | mitotic metaphase plate congression (GO:0007080) | 3.72713199 |
| 67 | regulation of protein activation cascade (GO:2000257) | 3.72614238 |
| 68 | nuclear envelope disassembly (GO:0051081) | 3.71250969 |
| 69 | membrane disassembly (GO:0030397) | 3.71250969 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 3.70952950 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.70490038 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 3.70450810 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.70005912 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.69284227 |
| 75 | coenzyme catabolic process (GO:0009109) | 3.67137611 |
| 76 | lipid oxidation (GO:0034440) | 3.66964132 |
| 77 | fatty acid catabolic process (GO:0009062) | 3.65886416 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.65368254 |
| 79 | macromolecular complex remodeling (GO:0034367) | 3.65368254 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65368254 |
| 81 | positive regulation of chromosome segregation (GO:0051984) | 3.64296381 |
| 82 | acylglycerol homeostasis (GO:0055090) | 3.63812454 |
| 83 | triglyceride homeostasis (GO:0070328) | 3.63812454 |
| 84 | protein localization to kinetochore (GO:0034501) | 3.63059743 |
| 85 | IMP biosynthetic process (GO:0006188) | 3.61868011 |
| 86 | DNA geometric change (GO:0032392) | 3.61816134 |
| 87 | DNA topological change (GO:0006265) | 3.58987641 |
| 88 | IMP metabolic process (GO:0046040) | 3.58073038 |
| 89 | monocarboxylic acid catabolic process (GO:0072329) | 3.57742367 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.55437477 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.55437477 |
| 92 | valine metabolic process (GO:0006573) | 3.54706136 |
| 93 | hyperosmotic salinity response (GO:0042538) | 3.53534120 |
| 94 | regulation of fibrinolysis (GO:0051917) | 3.52827163 |
| 95 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.52321287 |
| 96 | phospholipid efflux (GO:0033700) | 3.51790580 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.51343534 |
| 98 | proline biosynthetic process (GO:0006561) | 3.51328586 |
| 99 | non-recombinational repair (GO:0000726) | 3.51229091 |
| 100 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.51229091 |
| 101 | regulation of sister chromatid cohesion (GO:0007063) | 3.49071159 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48738134 |
| 103 | regulation of cholesterol esterification (GO:0010872) | 3.48511888 |
| 104 | tricarboxylic acid metabolic process (GO:0072350) | 3.46989144 |
| 105 | regulation of complement activation (GO:0030449) | 3.46402279 |
| 106 | telomere maintenance via recombination (GO:0000722) | 3.46218452 |
| 107 | sister chromatid segregation (GO:0000819) | 3.45545996 |
| 108 | mitotic sister chromatid segregation (GO:0000070) | 3.44191814 |
| 109 | protein carboxylation (GO:0018214) | 3.42638482 |
| 110 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.42638482 |
| 111 | ethanol oxidation (GO:0006069) | 3.40348436 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.39394191 |
| 113 | organic acid catabolic process (GO:0016054) | 3.39394191 |
| 114 | establishment of viral latency (GO:0019043) | 3.38478475 |
| 115 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.38307805 |
| 116 | oxaloacetate metabolic process (GO:0006107) | 3.36652567 |
| 117 | dicarboxylic acid catabolic process (GO:0043649) | 3.36520501 |
| 118 | regulation of fatty acid oxidation (GO:0046320) | 3.34734313 |
| 119 | tricarboxylic acid cycle (GO:0006099) | 3.34579457 |
| 120 | mitotic recombination (GO:0006312) | 3.32999334 |
| 121 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.32830736 |
| 122 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.30602669 |
| 123 | plasma lipoprotein particle clearance (GO:0034381) | 3.30211551 |
| 124 | regulation of RNA export from nucleus (GO:0046831) | 3.27170395 |
| 125 | drug catabolic process (GO:0042737) | 3.24460735 |
| 126 | succinate metabolic process (GO:0006105) | 3.23941573 |
| 127 | positive regulation of fatty acid oxidation (GO:0046321) | 3.22077074 |
| 128 | branched-chain amino acid catabolic process (GO:0009083) | 3.20566824 |
| 129 | tRNA aminoacylation for protein translation (GO:0006418) | 3.18931956 |
| 130 | cholesterol efflux (GO:0033344) | 3.18693742 |
| 131 | indolalkylamine metabolic process (GO:0006586) | 3.17890565 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 3.17211648 |
| 133 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.16530062 |
| 134 | carnitine transmembrane transport (GO:1902603) | 3.15508574 |
| 135 | regulation of cholesterol homeostasis (GO:2000188) | 3.15484440 |
| 136 | carnitine transport (GO:0015879) | 3.13689281 |
| 137 | amino-acid betaine transport (GO:0015838) | 3.13689281 |
| 138 | branched-chain amino acid metabolic process (GO:0009081) | 3.13644634 |
| 139 | glycine metabolic process (GO:0006544) | 3.12507404 |
| 140 | serine family amino acid metabolic process (GO:0009069) | 3.11051249 |
| 141 | amino acid activation (GO:0043038) | 3.09122203 |
| 142 | tRNA aminoacylation (GO:0043039) | 3.09122203 |
| 143 | nucleobase catabolic process (GO:0046113) | 3.07511886 |
| 144 | L-serine metabolic process (GO:0006563) | 3.07448556 |
| 145 | fatty acid homeostasis (GO:0055089) | 3.05845162 |
| 146 | DNA conformation change (GO:0071103) | 3.05594794 |
| 147 | benzene-containing compound metabolic process (GO:0042537) | 3.05469791 |
| 148 | thioester biosynthetic process (GO:0035384) | 3.04283621 |
| 149 | acyl-CoA biosynthetic process (GO:0071616) | 3.04283621 |
| 150 | NADH metabolic process (GO:0006734) | 3.02193280 |
| 151 | drug transmembrane transport (GO:0006855) | 3.02001998 |
| 152 | negative regulation of mRNA processing (GO:0050686) | 2.98365607 |
| 153 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.96660660 |
| 154 | establishment of chromosome localization (GO:0051303) | 2.91959023 |
| 155 | nuclear envelope organization (GO:0006998) | 2.91827429 |
| 156 | COPI coating of Golgi vesicle (GO:0048205) | 2.91045833 |
| 157 | Golgi transport vesicle coating (GO:0048200) | 2.91045833 |
| 158 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.88882001 |
| 159 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88432108 |
| 160 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88432108 |
| 161 | mRNA stabilization (GO:0048255) | 2.88421280 |
| 162 | RNA stabilization (GO:0043489) | 2.88421280 |
| 163 | purine nucleobase biosynthetic process (GO:0009113) | 2.88022790 |
| 164 | metaphase plate congression (GO:0051310) | 2.87912675 |
| 165 | nucleobase biosynthetic process (GO:0046112) | 2.87033728 |
| 166 | negative regulation of mRNA metabolic process (GO:1903312) | 2.86451128 |
| 167 | glutamine metabolic process (GO:0006541) | 2.82859796 |
| 168 | mRNA transport (GO:0051028) | 2.82859574 |
| 169 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.81803382 |
| 170 | regulation of mitotic spindle organization (GO:0060236) | 2.81248307 |
| 171 | mitochondrial fusion (GO:0008053) | 2.79080515 |
| 172 | protein export from nucleus (GO:0006611) | 2.78040650 |
| 173 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.77603234 |
| 174 | regulation of histone H3-K9 methylation (GO:0051570) | 2.76937894 |
| 175 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.76559169 |
| 176 | cellular hyperosmotic response (GO:0071474) | 2.73834699 |
| 177 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.73357552 |
| 178 | peptidyl-lysine dimethylation (GO:0018027) | 2.72715015 |
| 179 | rRNA transcription (GO:0009303) | 2.72633642 |
| 180 | chromosome condensation (GO:0030261) | 2.72005970 |
| 181 | regulation of chromosome segregation (GO:0051983) | 2.71346930 |
| 182 | transcription from mitochondrial promoter (GO:0006390) | 2.69383591 |
| 183 | regulation of translational elongation (GO:0006448) | 2.67709332 |
| 184 | regulation of centriole replication (GO:0046599) | 2.66683523 |
| 185 | histone arginine methylation (GO:0034969) | 2.65658486 |
| 186 | telomere maintenance via telomere lengthening (GO:0010833) | 2.64964821 |
| 187 | protein localization to chromosome (GO:0034502) | 2.64878649 |
| 188 | regulation of translational termination (GO:0006449) | 2.64274254 |
| 189 | ribosome biogenesis (GO:0042254) | 2.63538103 |
| 190 | DNA replication checkpoint (GO:0000076) | 2.59337491 |
| 191 | nucleic acid transport (GO:0050657) | 2.58471667 |
| 192 | RNA transport (GO:0050658) | 2.58471667 |
| 193 | establishment of RNA localization (GO:0051236) | 2.58471667 |
| 194 | viral mRNA export from host cell nucleus (GO:0046784) | 2.58370141 |
| 195 | mitochondrial DNA metabolic process (GO:0032042) | 2.57634880 |
| 196 | mRNA export from nucleus (GO:0006406) | 2.56556137 |
| 197 | RNA export from nucleus (GO:0006405) | 2.55095713 |
| 198 | regulation of spindle organization (GO:0090224) | 2.54100858 |
| 199 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.52627756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.26436706 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.35086626 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.57264392 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.48112558 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04802869 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.28569848 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.10502651 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.05904090 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.83237690 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.76494995 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.74164922 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.47800809 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.20202594 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.03054607 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.84511472 |
| 16 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.83571231 |
| 17 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.81346767 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.81311939 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.76173433 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.69630889 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.69403306 |
| 22 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.59228832 |
| 23 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.55778679 |
| 24 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.54504236 |
| 25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.50714020 |
| 26 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.49600895 |
| 27 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.32115356 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31893118 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.31771666 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26644018 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.26594152 |
| 32 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.24743975 |
| 33 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.19858641 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.10895198 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.04209518 |
| 36 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01706813 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 10.6444406 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99022696 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95672625 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93333213 |
| 41 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.92326449 |
| 42 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.90856932 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90036157 |
| 44 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89438991 |
| 45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.87929063 |
| 46 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86468074 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.83458215 |
| 48 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.79603199 |
| 49 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78310749 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77475498 |
| 51 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76168802 |
| 52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.74837483 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.69027214 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.68412071 |
| 55 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.68080310 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63943526 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.58215849 |
| 58 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.56515828 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56494608 |
| 60 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.53282921 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52879053 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.51774947 |
| 63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50717885 |
| 64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.48949171 |
| 65 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48913137 |
| 66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48711809 |
| 67 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.45108108 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43869773 |
| 69 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.40532153 |
| 70 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.37372148 |
| 71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37049842 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34434577 |
| 73 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.32566004 |
| 74 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32129006 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30241006 |
| 76 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30097539 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29524420 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27903277 |
| 79 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27215734 |
| 80 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.26794829 |
| 81 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.25269012 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25262018 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23214995 |
| 84 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22390420 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21940859 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20645194 |
| 87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20645194 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19429665 |
| 89 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.17452925 |
| 90 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.17108378 |
| 91 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16946279 |
| 92 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16105248 |
| 93 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15697170 |
| 94 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.14408591 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12734148 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11444225 |
| 97 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.11276049 |
| 98 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09402675 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09358917 |
| 100 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07757204 |
| 101 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.06870985 |
| 102 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.05851552 |
| 103 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05343203 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05262942 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05054785 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04872316 |
| 107 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04677525 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04651766 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04022341 |
| 110 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03752013 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03176193 |
| 112 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02271239 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99089498 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98036483 |
| 115 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97851027 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97327353 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94724313 |
| 118 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93857263 |
| 119 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91976122 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91270747 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90317006 |
| 122 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.90191016 |
| 123 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.89836002 |
| 124 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89305023 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88802823 |
| 126 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88628082 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87578292 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87495273 |
| 129 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87225674 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87044780 |
| 131 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85951754 |
| 132 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.85534985 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.84970879 |
| 134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.84771734 |
| 135 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84526771 |
| 136 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83300507 |
| 137 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.83016510 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82483126 |
| 139 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.80627146 |
| 140 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79399512 |
| 141 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78562139 |
| 142 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78045670 |
| 143 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.77874562 |
| 144 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77533302 |
| 145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76869658 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76702643 |
| 147 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75575763 |
| 148 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75374237 |
| 149 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75297677 |
| 150 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73148245 |
| 151 | AR_19668381_ChIP-Seq_PC3_Human | 0.73027274 |
| 152 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72941469 |
| 153 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.72891019 |
| 154 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72334085 |
| 155 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72334085 |
| 156 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.71992248 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.71552362 |
| 158 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71057331 |
| 159 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.68335643 |
| 160 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.68135202 |
| 161 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66779714 |
| 162 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66750909 |
| 163 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.66393915 |
| 164 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66374485 |
| 165 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64781332 |
| 166 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64301364 |
| 167 | KDM2B_26808549_Chip-Seq_K562_Human | 0.64010014 |
| 168 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63778570 |
| 169 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.63204164 |
| 170 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63007744 |
| 171 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.62910928 |
| 172 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.60553478 |
| 173 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.60283836 |
| 174 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60001039 |
| 175 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58676541 |
| 176 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.58446883 |
| 177 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58341724 |
| 178 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.58221287 |
| 179 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.58149544 |
| 180 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.57533984 |
| 181 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.57048321 |
| 182 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.56828317 |
| 183 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56652475 |
| 184 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.56531264 |
| 185 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.56479699 |
| 186 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.56353689 |
| 187 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.56312736 |
| 188 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.55571262 |
| 189 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.55304276 |
| 190 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55230667 |
| 191 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55224411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.45076167 |
| 2 | MP0005360_urolithiasis | 6.02327079 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.11777853 |
| 4 | MP0005365_abnormal_bile_salt | 4.90255045 |
| 5 | MP0010094_abnormal_chromosome_stability | 4.49634120 |
| 6 | MP0008057_abnormal_DNA_replication | 4.25589192 |
| 7 | MP0003111_abnormal_nucleus_morphology | 4.07208920 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.74293688 |
| 9 | MP0003693_abnormal_embryo_hatching | 3.66329744 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 3.59206336 |
| 11 | MP0003252_abnormal_bile_duct | 3.42845095 |
| 12 | MP0003077_abnormal_cell_cycle | 3.30395405 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 3.09997617 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.94335972 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.87455255 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.83757203 |
| 17 | MP0001730_embryonic_growth_arrest | 2.70724601 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.65699332 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.62147006 |
| 20 | MP0009840_abnormal_foam_cell | 2.53539245 |
| 21 | MP0008058_abnormal_DNA_repair | 2.50558785 |
| 22 | MP0005332_abnormal_amino_acid | 2.38688084 |
| 23 | MP0005083_abnormal_biliary_tract | 2.35887484 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.35780834 |
| 25 | MP0004130_abnormal_muscle_cell | 2.28842476 |
| 26 | MP0008007_abnormal_cellular_replicative | 2.23741872 |
| 27 | MP0003195_calcinosis | 2.16890007 |
| 28 | MP0003011_delayed_dark_adaptation | 2.11571451 |
| 29 | MP0009672_abnormal_birth_weight | 2.10052098 |
| 30 | MP0000350_abnormal_cell_proliferation | 2.05293503 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 2.02808695 |
| 32 | MP0000751_myopathy | 1.97432301 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.96697679 |
| 34 | MP0005380_embryogenesis_phenotype | 1.96478313 |
| 35 | MP0001672_abnormal_embryogenesis/_devel | 1.96478313 |
| 36 | MP0003646_muscle_fatigue | 1.88149937 |
| 37 | MP0002009_preneoplasia | 1.86723377 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.80459244 |
| 39 | MP0003984_embryonic_growth_retardation | 1.79633740 |
| 40 | MP0005451_abnormal_body_composition | 1.78114405 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.77987744 |
| 42 | MP0000609_abnormal_liver_physiology | 1.77566691 |
| 43 | MP0002088_abnormal_embryonic_growth/wei | 1.70516610 |
| 44 | MP0003868_abnormal_feces_composition | 1.70426447 |
| 45 | MP0001697_abnormal_embryo_size | 1.69640555 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.69102257 |
| 47 | MP0002080_prenatal_lethality | 1.68531335 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.66481391 |
| 49 | MP0003941_abnormal_skin_development | 1.62419234 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.56210505 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54338979 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.51034886 |
| 53 | MP0002084_abnormal_developmental_patter | 1.47270971 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.44320109 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.43885000 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.43466472 |
| 57 | MP0005187_abnormal_penis_morphology | 1.43432154 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.41211925 |
| 59 | MP0003718_maternal_effect | 1.40859472 |
| 60 | MP0005330_cardiomyopathy | 1.39648327 |
| 61 | MP0000747_muscle_weakness | 1.39432626 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.39104945 |
| 63 | MP0001764_abnormal_homeostasis | 1.37554171 |
| 64 | MP0002971_abnormal_brown_adipose | 1.36005940 |
| 65 | MP0002085_abnormal_embryonic_tissue | 1.35587545 |
| 66 | MP0000313_abnormal_cell_death | 1.35455156 |
| 67 | MP0004036_abnormal_muscle_relaxation | 1.35020321 |
| 68 | MP0002086_abnormal_extraembryonic_tissu | 1.34129133 |
| 69 | MP0001849_ear_inflammation | 1.33311983 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.30005517 |
| 71 | MP0003329_amyloid_beta_deposits | 1.26839367 |
| 72 | MP0010307_abnormal_tumor_latency | 1.26080803 |
| 73 | MP0004145_abnormal_muscle_electrophysio | 1.24812743 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.24408829 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.22969709 |
| 76 | MP0004043_abnormal_pH_regulation | 1.22323372 |
| 77 | MP0004197_abnormal_fetal_growth/weight/ | 1.21922609 |
| 78 | MP0004084_abnormal_cardiac_muscle | 1.20469631 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.19327010 |
| 80 | MP0000604_amyloidosis | 1.18416914 |
| 81 | MP0000358_abnormal_cell_content/ | 1.18248646 |
| 82 | MP0000537_abnormal_urethra_morphology | 1.12778471 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08587950 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 1.06754665 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.04940786 |
| 86 | MP0002269_muscular_atrophy | 1.04515949 |
| 87 | MP0000749_muscle_degeneration | 1.04459674 |
| 88 | MP0005535_abnormal_body_temperature | 1.04345141 |
| 89 | MP0008260_abnormal_autophagy | 1.03708010 |
| 90 | MP0004233_abnormal_muscle_weight | 1.02541215 |
| 91 | MP0005384_cellular_phenotype | 1.01929651 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.99119483 |
| 93 | MP0005620_abnormal_muscle_contractility | 0.98397993 |
| 94 | MP0005423_abnormal_somatic_nervous | 0.98283114 |
| 95 | MP0005621_abnormal_cell_physiology | 0.98177029 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.98018398 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.97642579 |
| 98 | MP0009703_decreased_birth_body | 0.94856668 |
| 99 | MP0002090_abnormal_vision | 0.94096198 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.93103359 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.92491057 |
| 102 | MP0005334_abnormal_fat_pad | 0.92264759 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.91032904 |
| 104 | MP0003136_yellow_coat_color | 0.90044748 |
| 105 | MP0001915_intracranial_hemorrhage | 0.89019484 |
| 106 | MP0005253_abnormal_eye_physiology | 0.88717342 |
| 107 | MP0002972_abnormal_cardiac_muscle | 0.87981765 |
| 108 | MP0000490_abnormal_crypts_of | 0.85840549 |
| 109 | MP0003786_premature_aging | 0.84952481 |
| 110 | MP0005670_abnormal_white_adipose | 0.84127122 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.82504040 |
| 112 | MP0002697_abnormal_eye_size | 0.82291048 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.81842980 |
| 114 | MP0000598_abnormal_liver_morphology | 0.81619825 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.80494198 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.80292673 |
| 117 | MP0004859_abnormal_synaptic_plasticity | 0.80170047 |
| 118 | MP0001661_extended_life_span | 0.77887261 |
| 119 | MP0005266_abnormal_metabolism | 0.77274643 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77108551 |
| 121 | MP0002092_abnormal_eye_morphology | 0.77047001 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 0.76166207 |
| 123 | MP0010630_abnormal_cardiac_muscle | 0.75957202 |
| 124 | MP0002166_altered_tumor_susceptibility | 0.75624270 |
| 125 | MP0009697_abnormal_copulation | 0.75391317 |
| 126 | MP0001293_anophthalmia | 0.75327174 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.75126629 |
| 128 | MP0000733_abnormal_muscle_development | 0.74852853 |
| 129 | MP0005448_abnormal_energy_balance | 0.74629605 |
| 130 | MP0002019_abnormal_tumor_incidence | 0.74540497 |
| 131 | MP0002254_reproductive_system_inflammat | 0.74357655 |
| 132 | MP0002106_abnormal_muscle_physiology | 0.73200993 |
| 133 | MP0001544_abnormal_cardiovascular_syste | 0.73094623 |
| 134 | MP0005385_cardiovascular_system_phenoty | 0.73094623 |
| 135 | MP0005408_hypopigmentation | 0.71383574 |
| 136 | MP0009642_abnormal_blood_homeostasis | 0.71377535 |
| 137 | MP0004085_abnormal_heartbeat | 0.71297812 |
| 138 | MP0003123_paternal_imprinting | 0.71143426 |
| 139 | MP0005171_absent_coat_pigmentation | 0.70859053 |
| 140 | MP0000428_abnormal_craniofacial_morphol | 0.70475726 |
| 141 | MP0002229_neurodegeneration | 0.69508110 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.69243708 |
| 143 | MP0008775_abnormal_heart_ventricle | 0.69026566 |
| 144 | MP0002876_abnormal_thyroid_physiology | 0.67559824 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.64166583 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.64101864 |
| 147 | MP0005647_abnormal_sex_gland | 0.63846964 |
| 148 | MP0005501_abnormal_skin_physiology | 0.63111070 |
| 149 | MP0004510_myositis | 0.62953120 |
| 150 | MP0004270_analgesia | 0.62909336 |
| 151 | MP0003315_abnormal_perineum_morphology | 0.62204483 |
| 152 | MP0003690_abnormal_glial_cell | 0.61492423 |
| 153 | MP0000759_abnormal_skeletal_muscle | 0.60883419 |
| 154 | MP0003861_abnormal_nervous_system | 0.60802892 |
| 155 | MP0006138_congestive_heart_failure | 0.60497261 |
| 156 | MP0005369_muscle_phenotype | 0.59343213 |
| 157 | MP0004484_altered_response_of | 0.59035115 |
| 158 | MP0003953_abnormal_hormone_level | 0.58805576 |
| 159 | MP0005084_abnormal_gallbladder_morpholo | 0.58596582 |
| 160 | MP0005257_abnormal_intraocular_pressure | 0.57898210 |
| 161 | MP0003566_abnormal_cell_adhesion | 0.57839649 |
| 162 | MP0005376_homeostasis/metabolism_phenot | 0.56624699 |
| 163 | MP0001727_abnormal_embryo_implantation | 0.56025697 |
| 164 | MP0002006_tumorigenesis | 0.56007658 |
| 165 | MP0001853_heart_inflammation | 0.54677137 |
| 166 | MP0003699_abnormal_female_reproductive | 0.54423415 |
| 167 | MP0000377_abnormal_hair_follicle | 0.53984457 |
| 168 | MP0000015_abnormal_ear_pigmentation | 0.52683829 |
| 169 | MP0002114_abnormal_axial_skeleton | 0.52035494 |
| 170 | MP0000266_abnormal_heart_morphology | 0.51838248 |
| 171 | MP0003943_abnormal_hepatobiliary_system | 0.50232299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.08488304 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.96712381 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.94230237 |
| 4 | Ketosis (HP:0001946) | 4.79194354 |
| 5 | Ketoacidosis (HP:0001993) | 4.54083458 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.42780951 |
| 7 | Xanthomatosis (HP:0000991) | 4.41077199 |
| 8 | Multiple enchondromatosis (HP:0005701) | 4.15214663 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.06263681 |
| 10 | Hyperammonemia (HP:0001987) | 4.01703182 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.00238932 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.97153814 |
| 13 | Chromsome breakage (HP:0040012) | 3.83125925 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.76800556 |
| 15 | Myoglobinuria (HP:0002913) | 3.67784626 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55825316 |
| 17 | Nemaline bodies (HP:0003798) | 3.49332678 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.43864154 |
| 19 | Exercise-induced myalgia (HP:0003738) | 3.42599589 |
| 20 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.34547765 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.34525790 |
| 22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33829406 |
| 23 | Epidermoid cyst (HP:0200040) | 3.33603283 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 3.32430014 |
| 25 | Complement deficiency (HP:0004431) | 3.32346110 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.29522090 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.29522090 |
| 28 | Microvesicular hepatic steatosis (HP:0001414) | 3.27300370 |
| 29 | Hyperglycinuria (HP:0003108) | 3.22849715 |
| 30 | Abnormality of glycolysis (HP:0004366) | 3.20422282 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.18373821 |
| 32 | Progressive muscle weakness (HP:0003323) | 3.14974750 |
| 33 | Cortical dysplasia (HP:0002539) | 3.08682831 |
| 34 | Hyperglycinemia (HP:0002154) | 3.07578691 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.03885344 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.99087979 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.95867042 |
| 38 | Exercise-induced muscle cramps (HP:0003710) | 2.95361621 |
| 39 | Progressive external ophthalmoplegia (HP:0000590) | 2.92967950 |
| 40 | Subaortic stenosis (HP:0001682) | 2.87318641 |
| 41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.87318641 |
| 42 | Central scotoma (HP:0000603) | 2.86467538 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.86024369 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.84154190 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.77590019 |
| 46 | Dysmetric saccades (HP:0000641) | 2.77472559 |
| 47 | Metabolic acidosis (HP:0001942) | 2.74161483 |
| 48 | Rhabdomyolysis (HP:0003201) | 2.69922478 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.68098197 |
| 50 | Gout (HP:0001997) | 2.67074914 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.66960778 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66960778 |
| 53 | Increased nuchal translucency (HP:0010880) | 2.60522799 |
| 54 | Hyperacusis (HP:0010780) | 2.60254838 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58391847 |
| 56 | Insomnia (HP:0100785) | 2.57522637 |
| 57 | Abnormality of methionine metabolism (HP:0010901) | 2.57418375 |
| 58 | Pigmentary retinal degeneration (HP:0001146) | 2.55400151 |
| 59 | Cholelithiasis (HP:0001081) | 2.54184141 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.54033090 |
| 61 | Cholecystitis (HP:0001082) | 2.54033090 |
| 62 | Rimmed vacuoles (HP:0003805) | 2.52120548 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.51505954 |
| 64 | Chorioretinal atrophy (HP:0000533) | 2.50921674 |
| 65 | Late onset (HP:0003584) | 2.50700725 |
| 66 | Sudden death (HP:0001699) | 2.50512656 |
| 67 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.50476738 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.49803522 |
| 69 | Fat malabsorption (HP:0002630) | 2.46200403 |
| 70 | Hyperbilirubinemia (HP:0002904) | 2.45766168 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.42487830 |
| 72 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42422263 |
| 73 | Hypercholesterolemia (HP:0003124) | 2.41588980 |
| 74 | Hepatocellular carcinoma (HP:0001402) | 2.40990240 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.40726390 |
| 76 | Cerebral edema (HP:0002181) | 2.40271103 |
| 77 | Skin nodule (HP:0200036) | 2.39137462 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 2.38133765 |
| 79 | Congenital stationary night blindness (HP:0007642) | 2.37108008 |
| 80 | Embryonal renal neoplasm (HP:0011794) | 2.36407779 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.29095047 |
| 82 | Hyperglycemia (HP:0003074) | 2.28503606 |
| 83 | Bundle branch block (HP:0011710) | 2.26892261 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.26441826 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 2.26298497 |
| 86 | Overriding aorta (HP:0002623) | 2.25332176 |
| 87 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.20944444 |
| 88 | Medulloblastoma (HP:0002885) | 2.19505824 |
| 89 | Joint hemorrhage (HP:0005261) | 2.18499832 |
| 90 | Calf muscle hypertrophy (HP:0008981) | 2.18313375 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 2.17129109 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 2.15811122 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.15649534 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 2.14525349 |
| 95 | Asymmetry of the thorax (HP:0001555) | 2.12763429 |
| 96 | Abnormality of the gallbladder (HP:0005264) | 2.12760980 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.07358308 |
| 98 | Hyporeflexia of lower limbs (HP:0002600) | 2.05285769 |
| 99 | Microglossia (HP:0000171) | 2.04131020 |
| 100 | Abnormality of complement system (HP:0005339) | 2.03455033 |
| 101 | Papillary thyroid carcinoma (HP:0002895) | 2.03429547 |
| 102 | Premature ovarian failure (HP:0008209) | 2.03114858 |
| 103 | Lethargy (HP:0001254) | 2.02139030 |
| 104 | Neonatal onset (HP:0003623) | 2.00673997 |
| 105 | Hyperuricemia (HP:0002149) | 1.98035932 |
| 106 | Increased purine levels (HP:0004368) | 1.98035932 |
| 107 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97872698 |
| 108 | Sensorimotor neuropathy (HP:0007141) | 1.97755242 |
| 109 | Proximal tubulopathy (HP:0000114) | 1.94733814 |
| 110 | Abnormality of chromosome stability (HP:0003220) | 1.92602466 |
| 111 | Urinary urgency (HP:0000012) | 1.92388275 |
| 112 | Acanthocytosis (HP:0001927) | 1.91977886 |
| 113 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91966342 |
| 114 | Neoplasm of the adrenal gland (HP:0100631) | 1.91558996 |
| 115 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90150613 |
| 116 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88604411 |
| 117 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88604411 |
| 118 | Vomiting (HP:0002013) | 1.87894231 |
| 119 | Myopathic facies (HP:0002058) | 1.86709403 |
| 120 | Scapular winging (HP:0003691) | 1.85969258 |
| 121 | Spontaneous abortion (HP:0005268) | 1.85930862 |
| 122 | Hammertoe (HP:0001765) | 1.85930089 |
| 123 | Uterine leiomyosarcoma (HP:0002891) | 1.85260956 |
| 124 | Leiomyosarcoma (HP:0100243) | 1.85260956 |
| 125 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84941241 |
| 126 | Palpitations (HP:0001962) | 1.83511028 |
| 127 | Birth length less than 3rd percentile (HP:0003561) | 1.82559530 |
| 128 | Syncope (HP:0001279) | 1.82428764 |
| 129 | Selective tooth agenesis (HP:0001592) | 1.81200689 |
| 130 | Ankyloglossia (HP:0010296) | 1.80858502 |
| 131 | Abnormality of the preputium (HP:0100587) | 1.80144238 |
| 132 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.80084099 |
| 133 | Gastrointestinal carcinoma (HP:0002672) | 1.80084099 |
| 134 | Scotoma (HP:0000575) | 1.79865391 |
| 135 | Missing ribs (HP:0000921) | 1.79555672 |
| 136 | Elfin facies (HP:0004428) | 1.77760748 |
| 137 | Areflexia of lower limbs (HP:0002522) | 1.77637943 |
| 138 | Muscle fiber inclusion bodies (HP:0100299) | 1.77475850 |
| 139 | Spastic diplegia (HP:0001264) | 1.77189069 |
| 140 | Conjunctival hamartoma (HP:0100780) | 1.77131097 |
| 141 | Achilles tendon contracture (HP:0001771) | 1.77065198 |
| 142 | Impaired social interactions (HP:0000735) | 1.76917056 |
| 143 | Abnormal social behavior (HP:0012433) | 1.76917056 |
| 144 | Acute hepatic failure (HP:0006554) | 1.75072184 |
| 145 | Lymphangioma (HP:0100764) | 1.74999028 |
| 146 | Overlapping toe (HP:0001845) | 1.74692923 |
| 147 | Metatarsus adductus (HP:0001840) | 1.74418625 |
| 148 | Brushfield spots (HP:0001088) | 1.74138696 |
| 149 | Pheochromocytoma (HP:0002666) | 1.73756163 |
| 150 | Cafe-au-lait spot (HP:0000957) | 1.73062791 |
| 151 | Insidious onset (HP:0003587) | 1.72686955 |
| 152 | Termporal pattern (HP:0011008) | 1.72686955 |
| 153 | Muscle stiffness (HP:0003552) | 1.72022922 |
| 154 | Atrioventricular block (HP:0001678) | 1.70043059 |
| 155 | Calcaneovalgus deformity (HP:0001848) | 1.69536207 |
| 156 | Embryonal neoplasm (HP:0002898) | 1.69353234 |
| 157 | Breech presentation (HP:0001623) | 1.69088242 |
| 158 | Proximal placement of thumb (HP:0009623) | 1.68911644 |
| 159 | Abnormal lung lobation (HP:0002101) | 1.68811936 |
| 160 | Deviation of the thumb (HP:0009603) | 1.68511907 |
| 161 | Impaired proprioception (HP:0010831) | 1.68336644 |
| 162 | Difficulty running (HP:0009046) | 1.67509737 |
| 163 | Ependymoma (HP:0002888) | 1.67139230 |
| 164 | Deep philtrum (HP:0002002) | 1.66313490 |
| 165 | Cutaneous melanoma (HP:0012056) | 1.65647829 |
| 166 | Meckel diverticulum (HP:0002245) | 1.64252692 |
| 167 | Abnormality of the foot musculature (HP:0001436) | 1.64239964 |
| 168 | Hepatoblastoma (HP:0002884) | 1.64075840 |
| 169 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.63789942 |
| 170 | Hypokinesia (HP:0002375) | 1.63619127 |
| 171 | Shoulder girdle muscle weakness (HP:0003547) | 1.62952750 |
| 172 | Foot dorsiflexor weakness (HP:0009027) | 1.61616466 |
| 173 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.59923623 |
| 174 | Renal duplication (HP:0000075) | 1.59087774 |
| 175 | Dysphonia (HP:0001618) | 1.59072141 |
| 176 | Neck muscle weakness (HP:0000467) | 1.58945118 |
| 177 | Abnormality of oral frenula (HP:0000190) | 1.58072258 |
| 178 | Back pain (HP:0003418) | 1.57598956 |
| 179 | Flat acetabular roof (HP:0003180) | 1.55709339 |
| 180 | Abnormality of the calf musculature (HP:0001430) | 1.54324691 |
| 181 | Secondary amenorrhea (HP:0000869) | 1.54212336 |
| 182 | Bowel incontinence (HP:0002607) | 1.54189061 |
| 183 | Type 1 muscle fiber predominance (HP:0003803) | 1.53792211 |
| 184 | Increased connective tissue (HP:0009025) | 1.53319673 |
| 185 | Postnatal microcephaly (HP:0005484) | 1.53057001 |
| 186 | Abnormality of pain sensation (HP:0010832) | 1.52896319 |
| 187 | Impaired pain sensation (HP:0007328) | 1.52896319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 4.01854872 |
| 2 | BCKDK | 3.93020034 |
| 3 | CDC7 | 3.60719369 |
| 4 | TRIB3 | 3.44346832 |
| 5 | SRPK1 | 3.26190401 |
| 6 | TSSK6 | 3.24044439 |
| 7 | TTK | 3.04105586 |
| 8 | OBSCN | 2.78090509 |
| 9 | EIF2AK3 | 2.72199529 |
| 10 | SMG1 | 2.63725841 |
| 11 | INSRR | 2.60571065 |
| 12 | BUB1 | 2.54164382 |
| 13 | PHKG1 | 2.52809690 |
| 14 | PHKG2 | 2.52809690 |
| 15 | PBK | 2.46867253 |
| 16 | KSR2 | 2.36609103 |
| 17 | MAP3K13 | 2.25599910 |
| 18 | EIF2AK1 | 2.19712781 |
| 19 | MAP2K4 | 2.06637336 |
| 20 | MARK1 | 2.01858704 |
| 21 | CDK12 | 2.01757092 |
| 22 | MAP3K9 | 1.84296577 |
| 23 | SIK1 | 1.81339894 |
| 24 | TTN | 1.81115014 |
| 25 | RET | 1.67637488 |
| 26 | NEK1 | 1.67101327 |
| 27 | PDK4 | 1.64627814 |
| 28 | PDK3 | 1.64627814 |
| 29 | TAOK3 | 1.63123675 |
| 30 | LATS2 | 1.60335649 |
| 31 | FRK | 1.58601764 |
| 32 | MAP3K7 | 1.55639280 |
| 33 | RPS6KB2 | 1.51766998 |
| 34 | LMTK2 | 1.50896187 |
| 35 | FGFR4 | 1.50224676 |
| 36 | PTK6 | 1.49130358 |
| 37 | FGFR2 | 1.43317820 |
| 38 | ALK | 1.42800541 |
| 39 | PIK3CG | 1.42740816 |
| 40 | WEE1 | 1.42737478 |
| 41 | MAP3K4 | 1.42098372 |
| 42 | MAP3K10 | 1.41353176 |
| 43 | ICK | 1.40367794 |
| 44 | KSR1 | 1.39287518 |
| 45 | FLT3 | 1.35674935 |
| 46 | MAPK11 | 1.31930795 |
| 47 | RIPK1 | 1.31705775 |
| 48 | TAF1 | 1.29872366 |
| 49 | STK24 | 1.25384363 |
| 50 | CHEK2 | 1.24421163 |
| 51 | PRKAA2 | 1.23912075 |
| 52 | VRK2 | 1.22581883 |
| 53 | NTRK3 | 1.22071274 |
| 54 | ATR | 1.18716813 |
| 55 | MKNK1 | 1.18224156 |
| 56 | CCNB1 | 1.17589686 |
| 57 | ERN1 | 1.16785002 |
| 58 | PLK3 | 1.16067801 |
| 59 | SCYL2 | 1.13359434 |
| 60 | CDK7 | 1.13250992 |
| 61 | PKN1 | 1.12738865 |
| 62 | DAPK2 | 1.10593815 |
| 63 | MKNK2 | 1.10115068 |
| 64 | CHEK1 | 1.09792017 |
| 65 | CDK6 | 1.08776500 |
| 66 | PRKD3 | 1.08402768 |
| 67 | MAPK12 | 1.07551625 |
| 68 | PLK1 | 1.06059683 |
| 69 | NME2 | 1.04362019 |
| 70 | PINK1 | 1.03673728 |
| 71 | MAP3K8 | 1.03358155 |
| 72 | PRKCH | 1.02117744 |
| 73 | EEF2K | 1.02112596 |
| 74 | PRKAA1 | 1.01240486 |
| 75 | CAMK1D | 1.00054387 |
| 76 | PAK6 | 0.99037657 |
| 77 | AURKB | 0.97307003 |
| 78 | RPS6KA4 | 0.95981890 |
| 79 | PRPF4B | 0.95819008 |
| 80 | JAK2 | 0.95698027 |
| 81 | PLK4 | 0.95203441 |
| 82 | PAK3 | 0.92874611 |
| 83 | ATM | 0.87530512 |
| 84 | CAMK1G | 0.86115258 |
| 85 | PIK3CA | 0.85671890 |
| 86 | MAP3K2 | 0.85450354 |
| 87 | EIF2AK2 | 0.81006281 |
| 88 | MAPKAPK3 | 0.79762129 |
| 89 | CDK4 | 0.79617852 |
| 90 | WNK4 | 0.77521253 |
| 91 | CDK2 | 0.75764419 |
| 92 | MST4 | 0.75312384 |
| 93 | MAP3K6 | 0.74063375 |
| 94 | SGK223 | 0.73339039 |
| 95 | SGK494 | 0.73339039 |
| 96 | DAPK1 | 0.72814543 |
| 97 | PRKCZ | 0.72748051 |
| 98 | RPS6KB1 | 0.72673629 |
| 99 | PDGFRA | 0.71243254 |
| 100 | ARAF | 0.70694366 |
| 101 | CDK1 | 0.69903568 |
| 102 | SGK3 | 0.69682323 |
| 103 | STK3 | 0.69246988 |
| 104 | NEK9 | 0.68972481 |
| 105 | MTOR | 0.68329411 |
| 106 | AURKA | 0.67056480 |
| 107 | PDK1 | 0.66255502 |
| 108 | ERBB4 | 0.65359700 |
| 109 | PAK4 | 0.65254064 |
| 110 | EPHA3 | 0.64890316 |
| 111 | MAP3K5 | 0.64784219 |
| 112 | RAF1 | 0.64595418 |
| 113 | DMPK | 0.63708986 |
| 114 | PDPK1 | 0.62946830 |
| 115 | BRSK1 | 0.62807287 |
| 116 | CAMKK1 | 0.61799471 |
| 117 | JAK1 | 0.59971251 |
| 118 | LATS1 | 0.59021677 |
| 119 | BRAF | 0.58114870 |
| 120 | STK4 | 0.58104297 |
| 121 | FGFR3 | 0.57970568 |
| 122 | SGK1 | 0.57014750 |
| 123 | CSNK1E | 0.56033341 |
| 124 | MAP2K7 | 0.55515021 |
| 125 | VRK1 | 0.54282897 |
| 126 | MINK1 | 0.53701010 |
| 127 | BRSK2 | 0.53609440 |
| 128 | PRKACG | 0.53500260 |
| 129 | BCR | 0.53040469 |
| 130 | CLK1 | 0.52625094 |
| 131 | PRKDC | 0.52374757 |
| 132 | ZAK | 0.51472362 |
| 133 | SGK2 | 0.51126469 |
| 134 | GRK1 | 0.50067251 |
| 135 | IRAK2 | 0.48601922 |
| 136 | NEK2 | 0.47771955 |
| 137 | CDK9 | 0.47564232 |
| 138 | BRD4 | 0.46327701 |
| 139 | STK11 | 0.46001099 |
| 140 | PDK2 | 0.45913746 |
| 141 | STK38L | 0.45528631 |
| 142 | CDK18 | 0.45423747 |
| 143 | CDK5 | 0.44872637 |
| 144 | MAPK10 | 0.44667065 |
| 145 | MAPKAPK5 | 0.44567000 |
| 146 | MAP3K1 | 0.44090142 |
| 147 | MUSK | 0.43928078 |
| 148 | CDK15 | 0.43201472 |
| 149 | PRKCQ | 0.43171982 |
| 150 | CSNK2A2 | 0.43102926 |
| 151 | NEK6 | 0.42711381 |
| 152 | UHMK1 | 0.42685978 |
| 153 | RPS6KA3 | 0.42616259 |
| 154 | CSNK1G3 | 0.41669776 |
| 155 | MAP2K1 | 0.41579873 |
| 156 | AKT2 | 0.41073032 |
| 157 | CDK14 | 0.40567354 |
| 158 | CDK8 | 0.39440788 |
| 159 | MAPK13 | 0.39102342 |
| 160 | PRKD1 | 0.38925611 |
| 161 | STK39 | 0.38246602 |
| 162 | CDK11A | 0.37380906 |
| 163 | ILK | 0.37344346 |
| 164 | CSNK1D | 0.37300739 |
| 165 | TYK2 | 0.36491272 |
| 166 | ERBB2 | 0.35984784 |
| 167 | MAP2K6 | 0.35811043 |
| 168 | CSNK1G1 | 0.35259005 |
| 169 | MAPK14 | 0.33699779 |
| 170 | FGFR1 | 0.32624682 |
| 171 | CAMK2A | 0.32039344 |
| 172 | EPHB1 | 0.31440273 |
| 173 | NTRK2 | 0.31077452 |
| 174 | CAMK4 | 0.30806584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.22759097 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.03267094 |
| 3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.53995859 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.46125364 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45091929 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.27031694 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.20750731 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.01966285 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.83254367 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76975903 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.69657543 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61812131 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61036458 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.57386697 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54629569 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47588063 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41480532 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.39758226 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.35712885 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.32425094 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 2.32272473 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 2.30869761 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 2.29426358 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 2.15151223 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12591881 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.02922272 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.92350409 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87122323 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.85737899 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82503316 |
| 31 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.80376820 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.79010938 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.77770427 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76416409 |
| 35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.69089033 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64345877 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56282263 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.53630316 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53545311 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.45029748 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44891869 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44125454 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37339719 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.36628854 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.36260472 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35489205 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35124340 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32534532 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25498333 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22802037 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18768734 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16088908 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13838497 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12986723 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12861470 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.11850806 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11654820 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.09420281 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 1.07062212 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.05238683 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05174863 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03457104 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03169913 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01709337 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99430495 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96070019 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92466351 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92220951 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91643080 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.90427841 |
| 71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.89568772 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.88753498 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.88721253 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86690001 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84969084 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84500924 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81248679 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80460751 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.77564115 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76172793 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73532886 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73000697 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72304003 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71512814 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71154187 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70041566 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69405297 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69161625 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68169903 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66887081 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64883255 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64814558 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.62578212 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58347106 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56968493 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56968123 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55506126 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54899472 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54492873 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50346594 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49248593 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48937365 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.47715294 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46988298 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.45340621 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44899693 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43827965 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.43522964 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43346234 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41847583 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41802516 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41268549 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41071738 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.39133872 |
| 115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37140067 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37009465 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.36820746 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36325646 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36024094 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35618976 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34331495 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.33762165 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33676682 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32784555 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31464976 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31377361 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30695844 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30693625 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30302395 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29844099 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29350461 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28351081 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.27440511 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27273231 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27222407 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26586528 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26297324 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25602649 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.24324486 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22855916 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.22589692 |
| 142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21642958 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21253905 |
| 144 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20774004 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20167871 |
| 146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19375760 |
| 147 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.18394235 |
| 148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.17488483 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16132721 |
| 150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.13016372 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12400064 |
| 152 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11929983 |
| 153 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09949255 |
| 154 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.09776533 |
| 155 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09608064 |
| 156 | Circadian entrainment_Homo sapiens_hsa04713 | 0.08970377 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08690774 |
| 158 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.07554031 |
| 159 | Renin secretion_Homo sapiens_hsa04924 | 0.07114725 |

